These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10022724)

  • 1. Re: Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options.
    Kirkali Z
    J Urol; 1999 Mar; 161(3):926. PubMed ID: 10022724
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.
    Mongiat-Artus P
    Eur Urol; 2008 Dec; 54(6):1235-6. PubMed ID: 18715693
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.
    Burger M
    Eur Urol; 2008 Dec; 54(6):1236. PubMed ID: 18715704
    [No Abstract]   [Full Text] [Related]  

  • 4. Familial transitional cell carcinoma and the Lynch syndrome II.
    Greenland JE; Weston PM; Wallace DM
    Br J Urol; 1993 Aug; 72(2):177-80. PubMed ID: 8402022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options.
    Sijmons RH; Kiemeney LA; Witjes JA; Vasen HF
    J Urol; 1998 Aug; 160(2):466-70. PubMed ID: 9679899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations.
    Joost P; Therkildsen C; Dominguez-Valentin M; Jönsson M; Nilbert M
    Urology; 2015 Dec; 86(6):1212-7. PubMed ID: 26385421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.
    Rouprêt M; Yates DR; Comperat E; Cussenot O
    Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards a rational strategy for the surveillance of patients with Lynch syndrome (hereditary non-polyposis colon cancer) for upper tract transitional cell carcinoma.
    Acher P; Kiela G; Thomas K; O'Brien T
    BJU Int; 2010 Aug; 106(3):300-2. PubMed ID: 20553255
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening.
    Urakami S; Inoshita N; Oka S; Miyama Y; Nomura S; Arai M; Sakaguchi K; Kurosawa K; Okaneya T
    Int J Urol; 2018 Feb; 25(2):151-156. PubMed ID: 29164703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifocal transitional cell carcinoma in a patient with hereditary nonpolyposis colon cancer.
    Ong E; Joseph JV; Bramwell SP; Haites NE
    BJU Int; 2003 Feb; 91(3):297. PubMed ID: 12581024
    [No Abstract]   [Full Text] [Related]  

  • 11. Lynch syndrome in upper tract urothelial carcinoma: significance, screening, and surveillance.
    Pradere B; Lotan Y; Roupret M
    Curr Opin Urol; 2017 Jan; 27(1):48-55. PubMed ID: 27533503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree.
    Wagner A; Hendriks Y; Meijers-Heijboer EJ; de Leeuw WJ; Morreau H; Hofstra R; Tops C; Bik E; Bröcker-Vriends AH; van Der Meer C; Lindhout D; Vasen HF; Breuning MH; Cornelisse CJ; van Krimpen C; Niermeijer MF; Zwinderman AH; Wijnen J; Fodde R
    J Med Genet; 2001 May; 38(5):318-22. PubMed ID: 11333868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upper tract urothelial carcinoma: a clinicopathologic study including microsatellite instability analysis.
    Blaszyk H; Wang L; Dietmaier W; Hofstädter F; Burgart LJ; Cheville JC; Hartmann A
    Mod Pathol; 2002 Aug; 15(8):790-7. PubMed ID: 12181263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsatellite instability and transitional cell carcinoma of the upper urinary tract.
    Rouprêt M; Azzouzi AR; Cussenot O
    BJU Int; 2005 Sep; 96(4):489-92. PubMed ID: 16104897
    [No Abstract]   [Full Text] [Related]  

  • 15. Misclassification of Upper Tract Urothelial Carcinoma in Patients With Lynch Syndrome.
    Matin SF; Coleman JA
    JAMA Oncol; 2018 Jul; 4(7):1010. PubMed ID: 29710233
    [No Abstract]   [Full Text] [Related]  

  • 16. Universal Point of Care Testing for Lynch Syndrome in Patients with Upper Tract Urothelial Carcinoma.
    Metcalfe MJ; Petros FG; Rao P; Mork ME; Xiao L; Broaddus RR; Matin SF
    J Urol; 2018 Jan; 199(1):60-65. PubMed ID: 28797715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misclassification of Upper Tract Urothelial Carcinoma in Patients With Lynch Syndrome-Reply.
    Samadder NJ; Wong J; Curtin K
    JAMA Oncol; 2018 Jul; 4(7):1010. PubMed ID: 29710287
    [No Abstract]   [Full Text] [Related]  

  • 18. Upper urinary tract carcinoma in Lynch syndrome cases.
    Crockett DG; Wagner DG; Holmäng S; Johansson SL; Lynch HT
    J Urol; 2011 May; 185(5):1627-30. PubMed ID: 21419447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upper Urinary Tract Urothelial Carcinoma in Lynch Syndrome Patients: The Urologist Still Has a Role in Genetic Screening.
    Grobet-Jeandin E; Pinar U; Rouprêt M
    Eur Urol Oncol; 2022 Feb; 5(1):42-43. PubMed ID: 34980573
    [No Abstract]   [Full Text] [Related]  

  • 20. [Should we systematically screen for Lynch syndrome in patients with upper urinary tract carcinoma?].
    Olagui GS; Pignot G; Rouquette A; Vieillefond A; Amsellem-Ouazana D; de Longchamps NB; Radenen B; Zerbib M; Terris B
    Bull Cancer; 2014 Feb; 101(2):144-50. PubMed ID: 24556207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.